The Uromigos Episode 173: The ATLANTIS Trial—Maintenance Cabozantinib

By The Uromigos - Last Updated: November 11, 2022

Robert Jones, MD, talks about the hypothesis for ATLANTIS, its specific trial results, and more. The data was presented at ASCO 2022.

Post Tags:Uromigos-ASCO

Advertisement

Related Podcasts

Episode 374: Mechanisms of HIF Resistance

Uromigos-Kidney Cancer

Episode 372: FDA Accelerated Approval Process

Episode 371: TROPiCS-04 Results From ESMO Asia

Uromigos-Bladder Cancer

Episode 370: Artificial Intelligence in Medical Oncology

Episode 369: Paper of the Month With Bishoy Faltas

Uromigos-Bladder Cancer

Advertisement

Advertisement